Med-Tech Innovation February 13, 2023
Tamir Tal

Tamir Tal, CEO, Cordio Medical, explains how AI voice biomarker technology and the advancement of a diagnostic app from a smartphone can transform diagnosis of early diseases.

The use of voice biomarkers (the unique voice signature of an individual) for the early detection of various diseases is at the forefront of medical-grade speech signal processing and artificial intelligence (AI). The potential of voice biomarkers is advancing and opening new opportunities for diagnoses, risk prediction, clinical outcomes, and symptomology. As one of the most promising digital healthcare sectors, all age cohorts, especially the ageing population, may see the most benefit. Taking advantage of the 83% of men and women 50-64 years of age and 61% of people...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Provider, Technology, Voice Assistant
AI-enabled clinical data abstraction: a nurse’s perspective
Contextual AI launches Agent Composer to turn enterprise RAG into production-ready AI agents
OpenAI’s latest product lets you vibe code science
WISeR in 2026: Legal, Compliance, and AI Challenges That Could Reshape Prior Authorization for Skin Substitutes
Dario Amodei warns AI may cause ‘unusually painful’ disruption to jobs

Share Article